The industrial fermentation tank is a slow, expensive beast. It takes time for microbes to grow and produce their target chemicals, fuels, or medicines, and every hour of runtime burns energy and capital. For nearly a decade, a UK-based startup has been quietly working on a simple, if unusual, way to make the beast move faster: an organic extract made from waste bananas.
LyteGro, founded in 2015, sells BacLyte, a product it claims accelerates the growth of bacteria and yeast. The pitch is straightforward. For industries that rely on fermentation,from chemical manufacturing and bioenergy to pharmaceuticals and diagnostics,faster microbial growth means higher yields and lower costs per batch. The company’s wedge is the source material. By using banana waste, it positions the extract as a sustainable, circular input for the green economy [Maddyness UK, Feb 2023].
The research behind the banana
The technology traces back to founder Mark Lyte, a researcher whose work on how gut bacteria can influence behavior in mice was profiled by The New York Times in 2015 as foundational to the field [The New York Times, 2015]. According to a company profile, Lyte invented BacLyte after observing its effects on microbial growth, leading to the company's formation with a co-founder [Maddyness UK, Feb 2023]. This scientific pedigree is the bedrock of LyteGro’s claim, differentiating it from generic growth supplements. The company has since developed two main product lines: Propagreater, targeted at alcohol fermentations in distilling, and MediaBoost, aimed at enhancing microbial cultures for research and diagnostics like sepsis tests [Life Sciences Review, 2023].
A long runway with quiet traction
LyteGro’s journey is atypical for a venture-scale climatetech startup. Incorporated in April 2015, it has operated for nearly a decade without any disclosed funding rounds or named investors [Companies House, April 2015]. The company has established an Australian arm targeting distilling and bioenergy sectors, offering plant designs, production know-how, and patents, though no specific customer deployments are named in public sources [Grow AG, Unknown]. The most recent significant press was a profile in February 2023, which framed the company around turning agricultural waste into high-impact products [Maddyness UK, Feb 2023].
The business model appears to be a classic B2B play for industrial biology, selling a consumable input into established processes. The potential markets are vast but fragmented, ranging from bulk chemical production to high-value diagnostic test manufacturing.
- The efficiency bet. For a bulk fermenter, even a single-digit percentage reduction in process time can translate to meaningful operational savings. If BacLyte works as claimed, its value is measured in reduced energy use and increased annual output.
- The sustainability angle. Using banana waste as a feedstock adds a green credential, potentially appealing to producers under decarbonization pressure.
- The diagnostic wedge. In medical diagnostics, where speed can be critical, accelerating bacterial growth in culture-based tests could be a more targeted, higher-margin entry point.
The incumbent to beat
For a back-of-the-envelope sense of the stakes, consider a mid-sized ethanol plant. If BacLyte could shave just 5% off a standard 48-hour fermentation cycle, that’s about 2.4 hours saved per batch. Over a year, that adds up to weeks of additional production capacity without building a new tank. The unit economics hinge entirely on whether the cost of the banana extract is lower than the value of that recaptured time and the extra product made.
The company’s quiet, bootstrap-heavy path means it has avoided the hype cycle, but it also faces the classic challenges of a deep-tech startup with a long commercial runway. The lack of disclosed funding or marquee customers after nine years raises questions about commercial scalability and go-to-market execution. Its success will be determined by one simple metric: Can it consistently prove to a cost-conscious plant manager that BacLyte delivers a positive return on investment? To win, LyteGro must beat not a direct competitor, but the incumbent,the inertia of an industry perfectly happy with its existing, slower, microbial growth media.
Sources
- [Maddyness UK, Feb 2023] Meet LyteGro, turning waste bananas into high impact products for the green economy | https://www.maddyness.com/uk/2023/02/07/meet-lytegro-turning-waste-bananas-into-high-impact-products-for-the-green-economy/
- [The New York Times, 2015] Can the Bacteria in Your Gut Explain Your Mood? | https://www.nytimes.com/2015/06/28/magazine/can-the-bacteria-in-your-gut-explain-your-mood.html
- [Life Sciences Review, 2023] LyteGro | Top Biotech Company in UK - 2023 | https://www.lifesciencesreview.com/lytegro
- [Companies House, April 2015] Lytegro Limited | https://find-and-update.company-information.service.gov.uk/company/09532059
- [Grow AG, Unknown] UK startup explores fruitful opportunities in Australia | https://www.growag.com/article/uk-startup-explores-fruitful-opportunities-australia
- [Lytegro, Unknown] Lytegro | https://lytegro.com